These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 21193890)
41. The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up. Yapar Z; Kibar M; Yapar AF; Paydas S; Reyhan M; Kara O; Buyukdereli G; Aydin M; Kelle AP; Unal I; Disel U; Yavuz S; Sahin B; Erkisi M Nucl Med Commun; 2010 Jan; 31(1):59-66. PubMed ID: 19952921 [TBL] [Abstract][Full Text] [Related]
42. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
43. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer. Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773 [TBL] [Abstract][Full Text] [Related]
45. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary. Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988 [TBL] [Abstract][Full Text] [Related]
46. Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy. Eubank WB; Mankoff DA; Schmiedl UP; Winter TC; Fisher ER; Olshen AB; Graham MM; Eary JF AJR Am J Roentgenol; 1998 Oct; 171(4):1103-10. PubMed ID: 9763005 [TBL] [Abstract][Full Text] [Related]
47. The importance of 18F-FDG PET/CT, CT and X-rays in detecting primary stage III A lung cancer and the incidence of extra thoracic metastases. Sharma R; Tripathi M; D'Souza M; Jaimini A; Saw SK; Singh D; Mishra A; Mondal A Hell J Nucl Med; 2009; 12(1):22-5. PubMed ID: 19330177 [TBL] [Abstract][Full Text] [Related]
48. Imaging evaluation of chest wall disorders in children. Fefferman NR; Pinkney LP Radiol Clin North Am; 2005 Mar; 43(2):355-70. PubMed ID: 15737373 [TBL] [Abstract][Full Text] [Related]
49. Dual-headed coincidence PET vs. dedicated PET/CT in the evaluation of thoracic malignancies. Bergström S; Holgersson G; Bergqvist JE; Bergqvist M; Ekman S; Stenström M In Vivo; 2010; 24(2):235-8. PubMed ID: 20364002 [TBL] [Abstract][Full Text] [Related]
50. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404 [TBL] [Abstract][Full Text] [Related]
51. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. Yuan S; Yu Y; Chao KS; Fu Z; Yin Y; Liu T; Chen S; Yang X; Yang G; Guo H; Yu J J Nucl Med; 2006 Aug; 47(8):1255-9. PubMed ID: 16883002 [TBL] [Abstract][Full Text] [Related]
52. Imaging of thoracic cavity tumors. Hayes SA; Plodkowski AJ; Ginsberg MS Surg Oncol Clin N Am; 2014 Oct; 23(4):709-33. PubMed ID: 25246047 [TBL] [Abstract][Full Text] [Related]
53. Askin (PNET) Tumor Unmasked by Trauma in a Young Male Patient. Ray AC; Aditya S; Jana PK; Chatterjee A; Sarkar A; Mehta J; Mukhopadhyay J J Assoc Physicians India; 2016 Mar; 64(3):82-85. PubMed ID: 27731566 [TBL] [Abstract][Full Text] [Related]
54. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors]. Wu ZJ; Zhang YX; Wei H; Jia Q Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544 [TBL] [Abstract][Full Text] [Related]
55. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle. Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129 [TBL] [Abstract][Full Text] [Related]
57. [Clinical evaluation of 18-fluorine fluorodeoxyglucose positron emission tomography-CT imaging in head and neck tumors]. Li XP; Liang Y; Liu X; Wang QS; Wu HB Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):298-301. PubMed ID: 15338869 [TBL] [Abstract][Full Text] [Related]
58. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185 [TBL] [Abstract][Full Text] [Related]
59. Giant thoracic ganglioneuroma in a pediatric patient: staging and restaging with ¹⁸F-FDG PET-CT. Agarwal KK; Sharma P; Kc SS; Bal C; Kumar R Rev Esp Med Nucl Imagen Mol; 2014; 33(5):310-1. PubMed ID: 25017382 [No Abstract] [Full Text] [Related]
60. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]